About Us
Built on Science. Designed for Results. Trusted Worldwide.
Founded in 1970, Candela is a global leader in medical aesthetic devices, delivering advanced technologies backed by clinical, technical, and business support.
55
Years of Innovation44,000
Devices Installed Wordlwide60+
Countries Located"To advance aesthetic medicine through clinically proven, safe, and reliable solutions that empower providers to deliver exceptional results with confidence."
55+ Years of Innovation
Candela is founded as an industrial laser company in Wayland, Massachusetts, USA
First pulsed-dye laser based on the theory of selective photothermolysis is developed.
FDA clearance is received for the SPT-1 device, the first pulsed dye laser, leading to the development of the industry’s gold standard for vascular treatments.
Combining technologies and expertise to expand innovation and strengthen a broader portfolio of aesthetic solutions under Syneron-Candela.
The Alexandrite laser is FDA cleared for permanent hair reduction.
Smoothbeam™ 1450 nm diode laser is launched for the treatment of acne vulgaris, acne scars, and periorbital wrinkles
The VelaShape® I system is introduced, the first system incorporating RF and IR for the temporary improvement of cellulite
The Vbeam Perfecta® device, a world leader in the treatment of vascular lesions is introduced
The elos Plus®, eMatrix™, and eTwo® systems are introduced with RF technology for aesthetic applications Launch of the Alex TriVantage system
The CO2RE® system is launched
GentleLase™ system is introduced
The GentleMax Pro® device is introduced, combining the 755 nm Alexandrite and 1064 nm Nd:YAG lasers The first focused pulsed ultrasound device, the UltraShape® system, is added to the portfolio
The Profound® system, the first tempera- ture-controlled RF microneedling device is commercialized The PicoWay® 2-wavelength picosecond laser platform is introduced
The PicoWay 3rd wavelength, 785 nm and Resolve module for the PicoWay device are introduced The CO2RE® Intima module for women’s health is introduced
Nordlys® platform introduced
Exceed™ microneedling device introduced PicoWay 730 nm handpiece and Resolve Fusion 532 nm handpiece are introduced
Non-ablative fractional resurfacing system introduced with 1550 and 1940 applicators FDA clearance of 1940 for benign pigmented lesions
GentleMax Pro Plus® system is introduced The PicoWay® laser is FDA-cleared to treat Melasma, Nevus of Ota, lentigines and Café au Lait Macules Matrix™ skin renewal workstation is introduced
Vbeam® Family FDA-cleared to include the pediatric population for port wine stains and infantile hemangiomas
GLX Delivery System for GentleMaxPro Plus® introduced
Glacē™ treatment is launched globally Vbeam® Pro, the advanced PDL and Nd:YAG platform is introduced
Our Core Values
Science
We are grounded in clinical evidence and scientific rigor, ensuring every solution is designed to deliver safe, effective outcomes.
Results
We are committed to delivering real, visible results that providers trust and patients can see.
Trust
We build lasting partnerships through reliability, transparency, and consistent performance.
Supporting Patients in Need
Candela supports various charities by using our technologies to help patients with traumatic scarring, vascular defects, birth marks and other painful or socially debilitating problems.
Candela Leadership
Geoffrey Crouse
CEO
Thomas Bailey
CFO
Mary Trout
CCO
Alex Moulle-Berteaux
CMO
Lisa Soderquist
CHRO
Michael Davidson
SVP, Global Operations
Lesley Fronio
Group SVP, Product Strategy and Innovation
Steven Ross
SVP, CIO, Global IT Strategy and Operations
Robert Blood
CLO
